RvT4 molecule boosts the body’s defenses against atherosclerosis in rheumatoid arthritis patients

Researchers from Queen Mary University of London have found that the molecule RvT4 enhances the body’s natural defences against atherosclerosis (hardening of the arteries) in patients with rheumatoid arthritis.

CHEST wins $100,000 grant to improve diagnostic excellence in interstitial lung disease

The American College of Chest Physicians (CHEST) was awarded a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to improve diagnostic excellence in

December 22, 2023

Preeclampsia Can Be Fatal. New Blood Tests Aim to Determine Who Is at Risk.

When patients are expecting a baby, they hope nothing goes wrong. But at least one in 20 people who are pregnant develop preeclampsia, a high

June 26, 2024

FDA officials raise concerns with immunotherapy overuse for early-stage cancer patients: #AACR24

SAN DIEGO — As immunotherapies become more widely used before and after cancer surgery, the FDA is worried that some patients may be receiving the

April 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.